Calcium-dependent arrhythmias in transgenic mice with heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 2 53-2, 2003, Pages

  London, Barry ^a,d   Baker, Linda C ^b   Lee, Joon S ^a   Shusterman, Vladimir ^a   Choi, Bum Rak ^b   Kubota, Toru ^a   McTiernan, Charles F ^a   Feldman, Arthur M ^c   Salama, Guy ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Genetically engineered mice; Optical mapping

Indexed keywords

CALCIUM; TUMOR NECROSIS FACTOR ALPHA;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CONDUCTANCE; CONTROLLED STUDY; DISEASE MODEL; EXTRASYSTOLE; GENE OVEREXPRESSION; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART DILATATION; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; SURVIVAL; TRANSGENIC MOUSE;

EID: 0037305207     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00431.2002     Document Type: Article

References (43)

1. Arai M, Alpert NR, MacLennan DH, Barton P, and Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469, 1993.
2. Baker LC, London B, Choi BR, Koren G, and Salama G. Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 86: 396-407, 2000.
3. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 73: 379-385, 1993.
4. Beuckelmann DJ, Nabauer M, and Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85: 1046-1055, 1992.
5. CAST, The Cardiac Arrhythmia Suppression Trial Investigators. Preliminary reporte of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 406-412, 1989.
6. i waves in cardiac myocytes. Am J Physiol Cell Physiol 270: C148-C159, 1996.
7. Choi BR and Salama G. Simultaneous maps of optical action potentials and calcium transients in guinea-pig hearts: mechanisms underlying concordant alternans. J Physiol 529: 171-188, 2000.
8. Del Nido P, Glynn P, Buenaventura P, Salama G, and Koretsky AP. Fluorescent measurements of calcium transients in perfused rabbit heart using Rhod-2. Am J Physiol Heart Circ Physiol 274: H728-H741, 1998.
9. 2 in the perfused mouse heart using manganese quenching. Cell Calcium 29:217-224, 2001.
10. El-Sherif N, Chinushi M, Caref EB, and Restivo M. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns. Circulation 96: 4392-4399, 1997.
11. Fozzard HA. Afterdepolarizations and triggered activity. Basic Res Cardiol 87, Suppl 2: 105-113, 1992.
12. Frazier DW, Wolf PD, Wharton JM, Tang ASL, Smith WM, and Ideker RE. Stimulus-induced critical point: a mechanism for electrical initiation of re-entry in normal canine myocardium. J Clin Invest 83: 1039-1052, 1989.
13. to,s: early afterdepolarizations, atrioventricular block and ventricular arrhythmias in mice lacking Kv1.4 and expressing a dominant-negative Kv4 α subunit. Circ Res 87: 73-79, 2001.
14. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, and Fishman GI. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88: 333-339, 2001.
15. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, and Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with endstage heart failure. Circ Res 61: 70-76, 1987.
16. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DH, Marban E, and Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78: 262-273, 1996.
17. Kadokami T, McTiernan CF, Kubota T, Frye CS, and Feldman AF. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest 106: 589-597, 2000.
18. Kubota T, Bounoutas GS, Miyagishima M, Kadokami T, Sanders VJ, Bruton C, Robbins PD, McTiernan CF, and Feldman AM. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 101: 2518-2525, 2000.
19. Kubota T, McTiernan CF, Frye CS, Slawson SE, Semster BH, Koretsky AP, Demetris AJ, and Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res 81: 627-635, 1997.
20. to and confers susceptibility to ventricular tachycardia. Cell 107: 801-813, 2001.
21. 2+ release in the heart. Cardiovasc Res 26: 193-214, 1992.
22. Levine B, Kalman J, Mayer L, Fillit HM, and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 223: 236-24, 1990.
23. K,slow and resistance to drug-induced QT prolongation. Circ Res 88: 940-946, 2001.
24. London B, Jeron A, Zhou J, Buckett P, Han X, Mitchell GF, and Koren G. Long QT and ventricular arrhythmias in transgenic mice expressing the N-terminus and first transmembrane segment of a voltage-gated potassium channel. Proc Natl Acad Sci USA 95: 2926-2931, 1998.
25. Nabauer M, Beuckelmann DJ, and Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 73: 386-394, 1993.
26. Nguyen-Tran VT, Kubalak SW, Minamisawa S, Fiset C, Wollert KC, Brown AB, Ruiz-Lozano P, Barrere-Lemaire S, Kondo R, Norman LW, Gourdie RG, Rahme MM, Feld GK, Clark RB, Giles WR, and Chien KR. A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell linkages. Cell 102:671-682, 2000.
27. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, and Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. I. Experimental Studies. Circ Res 84: 562-570, 1999.
28. Owens LM, Fralix TA, Murphy E, Cascio WE, Gettes LS, and the Experimental Cardiology Group. Correlation of ischemia-induced extracellular and intracellular ion changes to cell-to-cell electrical uncoupling in isolated blood-perfused rabbit hearts. Circulation 94: 10-13, 1996.
29. Perreault CL, Shannon RP, Komamura K, Vatner S, and Morgan JP. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacinginduced heart failure. J Clin Invest 89: 932-938, 1992.
30. Peters NS and Wit AL. Myocardial architecture and ventricular arrhythmogenesis. Circulation 97: 1746-1754, 1998.
31. Peters NS, Green CR, Poole-Wilson PA, and Severs NJ. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 88: 864-875, 1993.
32. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, and Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103: 196-200, 2001.
33. Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn II GW, Ross J Jr, Chien KR, and Brown JH. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest 103: 1627-1634, 1999.
34. Salama G, Kanai A, and Effimov IR. Subthreshold stimulation of purkinje fibers interrupts ventricular tachycardia in intact hearts. Experimental study with voltage-sensitive dyes and imaging techniques. Circ Res 74: 604-619, 1994.
35. i restores uncoupled β-adrenergic signaling in isolated perfused transgenic mouse hearts. Circ Res 88: 9-11, 2001.
36. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, and Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10: 189-194, 2001.
37. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, and Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27: 1201-1206, 1996.
38. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, and Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93: 704-771, 1996.
39. Vermeulen JT, McGuire MA, Opthof T, Coronel de BJM R, Klopping C, and Janse MJ. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res 28: 1547-1554, 1994.
40. ++. J Gen Physiol 95: 1061-1075, 1990.
41. Witt AL, Alessie MA, Bonke FIM, Lammers W, Smeets J, and Fenolio JJ Jr. Electrophysiologic mapping to determine the mechanism of experimental ventricular tachycardia induced by premature impulses. Am J Cardiol 49: 166-185, 1982.
42. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, and Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 92: 2303-2312, 1993.
43. Zipes D. Genesis of cardiac arrhythmias: Electrophysiological considerations. Management of cardiac arrhythmias: Pharmacological, electrical, and surgical techniques. Specific arrhythmias: diagnosis and treatment. In: Heart Disease: A Textbook of Cardiovascular Medicine, edited by Braumwald E. Philadelphia, PA: Saunders, 1997, p. 548-704.